Never Skip Double-Checking of Label Reconciliation in GMP Packaging
Remember: GMP requires thorough reconciliation of printed labels before and after packaging—skipping this control step can lead to product mix-ups or recalls.
Why This Matters in GMP
Label reconciliation is a critical step in pharmaceutical packaging to ensure that all issued, used, and returned labels are accounted for. Skipping double-checking or failing to reconcile labels accurately can result in products being misbranded, wrongly shipped, or containing incorrect dosage instructions. This compromises patient safety, product integrity, and brand trust. Errors in labeling are one of the most common causes of product recalls. GMP demands that no batch is released unless label reconciliation is completed, verified, and approved by QA.
Regulatory and Compliance Implications
FDA 21 CFR Part 211.125 outlines requirements for label control and reconciliation. EU GMP Chapter 5 mandates strict labeling procedures with accurate reconciliation of label quantities. WHO GMP and Schedule M enforce procedures for label issuance, return, destruction, and verification. During audits, inspectors review label reconciliation records, packaging logs, deviation reports, and product release documentation. Failure to reconcile labels or relying on visual verification alone can result in critical observations and batch rejection.
Implementation Best Practices
- Ensure
Regulatory References
- FDA 21 CFR Part 211.125 – Labeling Control and Reconciliation
- EU GMP Chapter 5 – Packaging and Labeling Controls
- WHO GMP – Label Reconciliation and Packaging Requirements
- Schedule M – Label Issuance and Verification Procedures